In previous studies, analysis of estrogen receptor-negative human endometrial carcinoma (HEC-1-A) cells that were genetically engineered to over- or under-express KLF9 identified serum-dependent mitogenic functions for this nuclear protein, based on its influence on cell phenotype and gene expression changes that support increased proliferation [21,22]. This evidence concerns the gene KLF9 and endometrial carcinoma.